EN DE
Watch Helixmith Co. Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Helixmith Co. Ltd (084990) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Helixmith Co. Ltd stock KRW 774, price KRW 3,465, that is 77.7% below the price, quality 51 out of 100. Rating: strongly overvalued. Calculated from audited financials with 2 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Non-Cyclicals KR · ISIN KR7084990001

HC Helixmith Co. Ltd logo Thin data Nov 8, 2026

Helixmith Co. Ltd

084990 · KQ
Very expensive, in a downtrend

Our calculation puts a fair price 78% below what the stock costs today.

Low debt
Revenue last quarter +18% vs. a year ago.
Quality 51/100
Fair value 774.11 KRW · Strongly overvalued
Weak Growth (revenue 5y −9.6 %/yr in KRW)
Loss-making · -16.7% net margin (FY2025)
Negative free cash flow
Trails peers (2/8)
Narrow moat 17/100
Thin data
Watch Helixmith Co. Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

36,273 KRW 2,185 KRW Fair Value 774.11 KRW Jun 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.

How to read this chart

60‑month range 2,185 KRW – 36,273 KRW · fair‑value band 756.32 KRW – 802.73 KRW · the 3,465 KRW price screens above the 774.11 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.

Follow Helixmith Co. in your weekly email

Every Wednesday you see whether Helixmith Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Helixmith Co., Ltd, a biotechnology company, discovers and develops biopharmaceuticals for human diseases.

Show moreShow less

The company has a pipeline of novel biologics and herbal therapeutics in the areas of cardiovascular disease, cancer, and immune disorder, with clinical studies ongoing in the United States, Korea, and China.

Its flagship product is VM202, a DNA-based drug for cardiovascular and neurological diseases.

The company's pipeline products include VM206, a therapeutic cancer vaccine targeting HER2/neu positive breast or ovarian cancer; and VM501, a re-engineered form of interleukin 11 targeting chemotherapy-induced thrombocytopenia.

Its clinical trials biologics comprise VM202-DPN, VM202-PAD, VM501, VM202-ALS, VM202-CAD, and VM206. The company was formerly known as ViroMed Co., Ltd. and changed its name to Helixmith Co., Ltd in April 2019. Helixmith Co., Ltd was incorporated in 1996 and is headquartered in Seoul, South Korea.

Stock analysis

Helixmith Co. Ltd (084990) currently trades at 3,465 KRW, while our model-based Fair Value estimate is 774.11 KRW, 78% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 2 models at a data quality of 94/100, which puts the data coverage at low.

Scenario range: 756.32 KRW (bear) to 802.73 KRW (bull), the price of 3,465 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 51/100 (solid quality), in the Consumer Non-Cyclicals sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Helixmith Co. Ltd reported revenue of 2.6B KRW in FY2025 versus 2.3B KRW in FY2021, a compound +2.9%/yr. Reported net income was −435M KRW in FY2025.

Key figures

Market cap 160B KRW (≈ $118M) Micro · P/S ratio 59.3 · Net margin −16.7% · Return on equity −803% · Return on assets (EBIT) −21.2% (5-year average) · Operating margin −1,924% · Revenue (TTM) 2.9B KRW · Revenue growth (YoY) +18.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 17 out of 100 (medium confidence).

What moves the price

The share trades about 63% below its 52-week high and 24% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Non-Cyclicals peers we cover trades at −26% fair-value upside, at −78%, 084990 screens richer than that median.

Fair Value models

Bear 756.32 KRW Fair Value 774.11 KRW Bull 802.73 KRW
Price 3,465 KRW · Downside -77.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Owner Earnings 756.32 KRW 774.11 KRW 802.73 KRW 78
NCAV (Graham) 1,182 KRW 1,791 KRW 2,239 KRW 54
All 2 models by family
DCF Models
Owner Earnings 756.32 KRW 774.11 KRW 802.73 KRW 78
Asset-Based
NCAV (Graham) 1,182 KRW 1,791 KRW 2,239 KRW 54

Open the full fair value analysis →

Quality Score breakdown

Overall quality 51/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 7
How much profit the company makes from its sales and capital
Quality Growth 49
Are margins and returns getting better?
Cashflow 33
Do the profits arrive as real cash?
Financial strength 92
Debt, balance sheet and risk of trouble
Investment 85
Does it invest with discipline instead of growing at any price?
Low Volatility 38
How calm the share price moves, does not count
Price momentum 24
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 5
Distance to the 52-week high, does not count
New shares 59
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−47.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−9.6%
Start year 2020 (pandemic). Over 10 years: −10.3% a year
Revenue growth 15 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.8%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−1,700.1% (2020) → −380.6% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

084990 screens overvalued: fair value 78% below the price. Compare with FB →

Compare Helixmith Co. Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Food & Tobacco · 27 stocks

Beats the industry median on 2/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 51 · Below median
Fair Value upside −77.7% · Bottom 25%
Profitability
Return on assets −0.3% · Bottom 25%
Net margin (12 months) −16.7% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 18.1% · Top 25%
Balance sheet
Debt / equity 0.00× · Lowest 25%

Valuation Multiplesvs Food & Tobacco median · lower = cheaper

P/B 1.12× · Pricier than median
P/S (12 months) 55.16× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 66
FUTURE (revenue growth)91 · sector 0
PAST (return on equity)0 · sector 0
HEALTH (low debt)100 · sector 97
DIVIDEND (yield)0 · sector 72

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Tobacco

Similar stocks

10 more Food & Tobacco stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
EASY BIO,Inc. 353810 4,955 KRW 14,865 KRW +200% vs 084990
MSC Co 009780 6,800 KRW 18,405 KRW +171% vs 084990
RFM RFM 5.15 PHP 7.77 PHP +51% vs 084990
CNPF CNPF 28.50 PHP 30.23 PHP +6% vs 084990
FB FB 47.50 PHP 34.97 PHP −26% vs 084990
AXLM AXLM 2.77 PHP 2.00 PHP −28% vs 084990
URC URC 61.65 PHP 41.28 PHP −33% vs 084990
DNL DNL 3.57 PHP 1.75 PHP −51% vs 084990
MONDE MONDE 6.40 PHP 1.25 PHP −80% vs 084990
LFM LFM 18.98 PHP 2.52 PHP −87% vs 084990

Explore undervalued stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Helixmith Co. Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Helixmith Co. Ltd Fair Value". https://www.fairvalue-calculator.com/stock/084990

Frequently asked questions

Is Helixmith Co. Ltd (084990) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of 774.11 KRW versus a price of 3,465 KRW, about 78% lower (overvalued).
What is the fair value of 084990?
Our model-based fair value for Helixmith Co. Ltd is 774.11 KRW (as of Nov 8, 2026), built from audited fundamentals. The current price: 3,465 KRW.
What is the quality score of 084990?
Helixmith Co. Ltd has a Quality Score of 51/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Helixmith Co. Ltd (084990)?
Our model-based price target is the fair value of 774.11 KRW (as of Nov 8, 2026) from 2 valuation models. Cautious scenario 756.32 KRW, optimistic scenario 802.73 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Helixmith Co. Ltd stock forecast for 2026?
Our models put fair value at 774.11 KRW, about 78% lower versus a price of 3,465 KRW (overvalued). Cautious scenario 756.32 KRW, optimistic scenario 802.73 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Helixmith Co. Ltd (084990)?
Helixmith Co. Ltd reported trailing-twelve-month revenue of about 2.9B KRW (latest available figure, as of Nov 8, 2026).
What is the intrinsic value of Helixmith Co. Ltd (084990)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Helixmith Co. Ltd it is 774.11 KRW per share (as of Nov 8, 2026), against a price of 3,465 KRW. It is the blended result of 2 valuation models in 2 families (DCF Models, Asset-Based).
Is Helixmith Co. Ltd stock overvalued or undervalued in 2026?
As of Nov 8, 2026, 084990 trades above its calculated fair value: price 3,465 KRW, fair value 774.11 KRW, a gap of about −78% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 084990?
No. The price is what the market pays today (3,465 KRW); the fair value is what the company's own numbers justify (774.11 KRW). For Helixmith Co. Ltd the two are 2,691 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Helixmith Co. Ltd worth?
The market values Helixmith Co. Ltd at about 160B KRW (market capitalisation, as of Nov 8, 2026). Per share that is 3,465 KRW; our models calculate a fair value of 774.11 KRW per share.
What do the bullish and bearish scenarios say about 084990?
Our models span a range for Helixmith Co. Ltd: cautious scenario 756.32 KRW, base 774.11 KRW, optimistic 802.73 KRW per share (as of Nov 8, 2026, price 3,465 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Helixmith Co. Ltd (084990)?
Balance-sheet figures for Helixmith Co. Ltd (as of Nov 8, 2026): debt of 0.00 per unit of equity. They feed the Quality Score of 51/100, which measures business quality independently of the share price.
How far is 084990 from its 52-week high?
Helixmith Co. Ltd trades at 3,465 KRW, about 63% below its 52-week high of 9,470 KRW and 24% above the low of 2,805 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 774.11 KRW is for.
Which stocks are comparable to Helixmith Co. Ltd?
From the same area (Consumer Non-Cyclicals) we also value FB, URC, MONDE, CNPF, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Helixmith Co. Ltd stock attractive at the current price?
The data as of Nov 8, 2026: price 3,465 KRW, calculated fair value 774.11 KRW (−78%), Quality Score 51/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 084990 calculated?
We run Helixmith Co. Ltd through 2 models from 2 families: DCF Models, Asset-Based. Every model gets the same audited fundamentals; the fair value of 774.11 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Helixmith Co. Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Helixmith Co. Ltd (084990)?
The closing price on Nov 6, 2026 was 3,465 KRW. Our model-based fair value is 774.11 KRW, about 78% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Helixmith Co. Ltd right now?
The price sits above even our optimistic bull case (802.73 KRW). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (51/100) and above fair value, neither a clear bargain nor a standout compounder. The models converge in a tight band (756.32 KRW to 802.73 KRW), unusually little disagreement for a valuation.

Key figures of Helixmith Co. Ltd

How large is the market capitalisation of Helixmith Co. Ltd (084990)?
The market capitalisation of Helixmith Co. Ltd is 160B KRW (≈ $118M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Helixmith Co. Ltd (084990)?
The price-to-sales ratio of Helixmith Co. Ltd is 59.3 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Helixmith Co. Ltd (084990)?
The net margin of Helixmith Co. Ltd is −16.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Helixmith Co. Ltd (084990)?
The return on equity (ROE) of Helixmith Co. Ltd is −803% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Helixmith Co. Ltd (084990)?
On an EBIT basis the return on assets of Helixmith Co. Ltd is −21.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Helixmith Co. Ltd (084990)?
The operating margin of Helixmith Co. Ltd is −1,924% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Helixmith Co. Ltd (084990)?
Revenue at Helixmith Co. Ltd is growing +18.1% versus a year earlier (3y avg −2.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Helixmith Co. Ltd (084990) generate?
The free cash flow of Helixmith Co. Ltd is −7.2B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Helixmith Co. Ltd (084990) carry?
The net debt of Helixmith Co. Ltd is 69.6B KRW (fiscal year 2019). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Helixmith Co. Ltd in the live analysis

One click puts Helixmith Co. Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.